SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 40 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,585,000 | -4.5% | 2,060,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,706,000 | -85.2% | 2,060,000 | -83.5% | 0.00% | -85.0% |
| Q4 2021 | $18,337,000 | -22.6% | 12,500,000 | -21.9% | 0.02% | -25.9% |
| Q3 2021 | $23,700,000 | +3.5% | 16,000,000 | -8.6% | 0.03% | -3.6% |
| Q1 2021 | $22,903,000 | -58.5% | 17,500,000 | -22.2% | 0.03% | -60.0% |
| Q4 2020 | $55,221,000 | +32.2% | 22,500,000 | +11.8% | 0.07% | +18.6% |
| Q3 2020 | $41,779,000 | +102.1% | 20,125,000 | +123.6% | 0.06% | +84.4% |
| Q2 2020 | $20,677,000 | +36.0% | 9,000,000 | -10.0% | 0.03% | +14.3% |
| Q1 2020 | $15,203,000 | +212.3% | 10,000,000 | +300.0% | 0.03% | +300.0% |
| Q4 2019 | $4,868,000 | -88.5% | 2,500,000 | -86.8% | 0.01% | -89.9% |
| Q2 2019 | $42,340,000 | +55.8% | 19,000,000 | +26.6% | 0.07% | +56.8% |
| Q1 2019 | $27,181,000 | – | 15,012,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
| Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
| CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
| Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
| Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
| D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |